Objectives: Despite the co-occurrence and clinically significant relationship between trauma exposure and smoking, there is little understanding of the mechanisms underlying the posttraumatic stress symptoms-smoking relationship. This study examined whether dysphoria (ie, a psychopathologic symptom dimension that reflects depression's core affective, cognitive, and psychomotor features) accounted for the covariance between posttraumatic stress symptom severity and an array of smoking processes among trauma-exposed daily smokers. Methods: Participants (n = 189; 47.6% female; M age = 41.15; SD = 12.47) were trauma-exposed, treatment-seeking daily cigarette smokers who completed measures of posttraumatic stress symptom severity, dysphoria, and 4 cognitive-based smoking processes that interfere with smoking cessation-avoidance/inflexibility to smoking, perceived barriers to smoking cessation, negative affect reduction motivation for smoking, and negative affect reduction/negative reinforcement expectancies from smoking. Results: Dysphoria indirectly and significantly accounted for the relationship between posttraumatic stress symptom severity and smoking outcomes. Conclusions: The present results provide initial empirical support that dysphoria accounts for the covariance between posttraumatic symptom severity and various clinically relevant smoking variables in trauma-exposed, treatment-seeking smokers. The findings suggest the
T rauma exposure is alarmingly high among the general population (Breslau et al., 2003; Frans et al., 2005) . The majority of trauma-exposed individuals recover from the traumatic event exposure, but a small subset fail to do so and develop posttraumatic stress disorder (PTSD) (Breslau et al., 2003) . Trauma-exposed individuals without PTSD are not at as high of risk for drug abuse or dependence as those who develop PTSD (Breslau et al., 2003) . Yet, trauma-exposed persons are at a greater risk for developing nicotine dependence relative to nontrauma-exposed persons. Compared with individuals not exposed to a traumatic event, trauma-exposed individuals (with or without PTSD) are more likely to be smokers, tend to smoke more heavily, have higher levels of nicotine dependence, and show poorer outcomes during quit attempts (Feldner et al., 2007; Zvolensky et al., 2008) . Trauma-exposed smokers are also particularly motivated to smoke to reduce negative affect and expect that smoking will reduce negative affect (Calhoun et al., 2011) , perhaps owing to the fact that smoking seems to temporarily relieve distress among such persons (Beckham et al., 2005) . Moreover, a cross-sectional study found that greater smoking rates and higher levels of nicotine dependence are related to PTSD and increased PTSD symptom severity (Beckham et al., 1997) . Despite the documented co-occurrence and clinically significant relationships between trauma exposure and smoking, there is little understanding of the mechanisms underlying the posttraumatic stress symptoms-smoking relationship.
Depression may be one common, affect-relevant mechanism linking posttraumatic stress symptom severity and smoking. Moderate to severe levels of depressive symptoms before smoking cessation treatment are frequently associated with poorer cessation outcomes (Niaura and Abrams, 2001; Cinciripini et al., 2003) . Some work suggests that dysphoria, a within-symptom cluster of depression, may be more related to smoking maintenance and relapse than other depressive symptoms (Leventhal et al., 2011) . Greater dysphoria is also linked to higher rates of smoking over time (Helstrom et al., 2009) , and smokers who endorse greater dysphoria are more vulnerable to dependent smoking and relapse as a means to attenuate dysphoria-related symptoms (Leventhal et al., 2011) .
Depressive symptoms also often co-occur with PTSD (Kessler et al., 1995) . For example, an extensive literature on early childhood trauma suggests that early exposure to stress is related to later symptoms of depression (Heim et al., 2008) . Moreover, those who developed PTSD are at a markedly increased risk for major depression (Breslau et al., 2003) . Trauma-exposed individuals without PTSD, however, were not at an increased risk for the onset of major depression. Indeed, recent work has linked posttraumatic stress symptom severity and dysphoria (Bernstein et al., 2011) . Theoretically, among trauma-exposed smokers, dysphoria may contribute to perceived challenges in quitting smoking and mood management, smoking motivation, and cognition. That is, among trauma-exposed smokers with posttraumatic stress symptoms, increased levels of dysphoria and negative cognition may contribute to greater (1) perceived obstacles to smoking cessation, and (2) perceived mood regulation benefits of smoking. Thus, dysphoria may, at least partially, explain the association between posttraumatic stress and factors that contribute to poor smoking cessation outcomes.
Confirmatory factor analyses have identified dysphoria, intrusion, avoidance, and hyperarousal as defining symptom clusters of PTSD (Simms et al., 2002) . These distinct clusters correlate differently with other psychiatric disorders. For example, the dysphoria cluster represents symptoms that are similar across depression and anxiety disorders, whereas the intrusion cluster includes phenotypically different symptoms across disorders (Simms et al., 2002) . Recent work found greater endorsement of dysphoric symptoms, as assessed by an emotional numbing factor of PTSD, related to being a heavy smoker versus a nonsmoker (Cook et al., 2009) . These data suggest that exploring components of PTSD symptomology among a trauma-exposed population may offer unique insights into the posttraumatic stress symptoms-smoking comorbidity. Although research links posttraumatic stress symptoms, dysphoria, and smoking, no research has explored the explanatory value of dysphoria in the relationship between PTSD symptom clusters (ie, intrusion, avoidance, or hyperarousal) and cognitive-based smoking processes. This represents a clinically noteworthy gap in the literature given the important role cognitive-based processes play in addiction and mental health.
Taken together, this study examined the potential explanatory role of dysphoria regarding the relationship between posttraumatic stress symptom severity, only including items that load on the intrusion, avoidance, or hyperarousal factors, and cognitive-based smoking processes of smoking, including (1) the tendency to respond with avoidance/inflexibility in the presence of aversive smoking-related thoughts, feelings, or internal sensations; (2) perceived barriers to smoking cessation; (3) negative affect reduction motivation for smoking; and (4) negative affect reduction/negative reinforcement expectancies from smoking ( Fig. 1 ). We hypothesized that dysphoria would explain the relationship between posttraumatic symptom severity and these smoking processes, and that these effects would not be explained by sex, the trait-like propensity to experience negative affect, and time since traumatic event.
METHODS

Participants
The sample consisted of 189 treatment-seeking, traumaexposed, adult daily smokers (47.6% female; M age = 41.15; SD = 12.47) who endorsed at least 1 lifetime criterion A traumatic event according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) (American Psychiatric Association, 2000) . Only participants who reported smoking at least 8 cigarettes a day during the past year, as indexed by the Smoking History Questionnaire (SHQ) (Brown et al., 2002) , were included. Exclusion criteria included suicidality and psychosis. Participants were primarily white adults (88.4%) and married or living with someone (42.9%) or never married (32.8%). Nearly one-third (31.2%) of participants completed some college, and 45.5% met criteria for at least 1 current (past year) psychological disorder. Participants reported an average daily smoking rate of 18.8 (SD = 8.97) cigarettes per day and daily smoking for an average of 23.0 years (SD = 12.69). The majority (67.2%) of participants reported that the traumatic event occurred more than 5 years ago.
Measures
Primary Predictors
Posttraumatic Diagnostic Scale. The Posttraumatic Diagnostic Scale (PDS) (Foa, 1995) is a 49-item self-report instrument that assesses trauma exposure and the presence of posttraumatic stress symptoms based on DSM-IV criteria (American Psychiatric Association, 2000) . Respondents report if they have experienced any of 13 traumatic events (eg, "natural disaster," "sexual or nonsexual assault by a stranger"), including an "other" category, and then indicate which event was most disturbing. Participants report how long ago the traumatic event occurred on a 6-point scale from 1 ("less than one month [ago]") to 6 ("more than 5 years [ago]"). In this study, only those participants indicating that they experienced, witnessed, or were confronted with a traumatic event that involved actual or threatened death or serious injury that was accompanied by a feeling of helplessness and terror (ie, met DSM-IV-TR defined criterion A trauma; American Psychiatric Association, 2000) were included. The PDS also assesses the past month frequency of the 17 DSM-IV-TR symptoms of PTSD for the most disturbing event endorsed from 0 ("not at all/only once") to 3 ("5 or more times a week/almost always"). For this study, 2 summary scores were created. The first score was the sum of items that load on the intrusion, avoidance, or hyperarousal symptom clusters in a 4-factor confirmatory factor analysis (PDS-IAH) (Simms et al., 2002; Yufik and Simms, 2010) ; items that load on the dysphoria system cluster were excluded. The PDS-IAH included 9 items (ie, items 22-28, 37, and 38). The second score was the sum of all 17 items (PDS-total). The PDS has evidenced excellent psychometric properties (Foa et al., 1997) , including high internal consistency (α = 0.92) and high test-retest reliability (κ = 0.74). The PDS demonstrated excellent internal consistency (PDS-IAH: Cronbach α = 0.88; PDS-total: Cronbach α = 0.93). 
Inventory of Depression and Anxiety Symptoms.
The Inventory of Depression and Anxiety Symptoms (IDAS) (Watson et al., 2007 ) is a 64-item self-report instrument that assesses distinct affect symptom dimensions within the past 2 weeks. Items are answered on a 5-point Likert scale ranging from "not at all" to "extremely." The Inventory of Depression and Anxiety Symptoms subscales show strong internal consistency, convergent and discriminant validity with psychiatric diagnoses and self-report measures, and short-term retest reliability (r = 0.79) with both community and psychiatric patient samples (Watson et al., 2007) . This study used the dysphoria subscale (eg, "I felt depressed"; 10 items). The dysphoria subscale demonstrated excellent internal consistency in the current sample (Cronbach α = 0.93).
Outcomes
Avoidance and Inflexibility Scale. The Avoidance and Inflexibility Scale (AIS) assesses avoidance and inflexibility related to smoking (Gifford and Lillis, 2009 ) on a Likerttype scale ranging from 1 ("not at all") to 5 ("very much"). Participants respond to 13 items, such as "How likely is it that these feelings will lead you to smoke?" and "To what degree must you reduce how often you have these thoughts in order not to smoke?" The AIS has demonstrated good internal consistency (Gifford and Lillis, 2009) . Higher scores represent more smoking-based avoidance or inflexibility in the presence of uncomfortable or difficult sensations or thoughts, whereas lower scores suggest more ability to accept difficult feelings or thoughts without allowing them to trigger smoking. In this study, the total score was used, and the scale demonstrated high internal consistency (Cronbach α = 0.93).
Barriers to Cessation Scale. The Barriers to Cessation Scale (BCS) assesses barriers associated with smoking cessation (Macnee and Talsma, 1995) . Participants report the extent to which they identify with 19 items according to a 4-point Likert-type scale (0 = "not a barrier" to 3 = "large barrier"). Researchers report good internal consistency regarding the total score and good content and predictive validity of the measure (Macnee and Talsma, 1995) . As with previous research, the total score summary statistic was utilized. This scale demonstrated high internal consistency (Cronbach α = 0.89).
Reasons for Smoking. The Reasons for Smoking
(RFS) assesses smoking motives (Ikard et al., 1969) . The psychometric properties of this scale have been well established (Shiffman, 1993) . The version of the RFS used consisted of 23 items, and items are rated on a 1 ("never") to 5 ("always") scale. Previous research lends support for a unique relationship among psychological vulnerabilities and the RFS-Negative Affect Reduction subscale (RFS-NA; 6 items) (Brown et al., 2001) ; thus, we utilized the RFS-NA in this study, which demonstrated high levels of internal consistency (Cronbach α = 0.89).
Smoking Consequences Questionnaire. The Smok-
ing Consequences Questionnaire (SCQ) (Brandon and Baker, 1991 ) is a 50-item self-report measure that assesses tobacco use outcome expectancies believed to underlie smoking motivation on a Likert-type scale, ranging from 0 ("completely unlikely") to 9 ("completely likely"). On the basis of previous research (Gonzalez et al., 2009) , we utilized the SCQ-Negative Reinforcement/Negative Affect Reduction subscale (SCQ-NR; 12 items). The SCQ-NR demonstrated high internal consistency (Cronbach α = 0.92).
Smoking History Questionnaire. The Smoking History Questionnaire (SHQ) assesses smoking rate, the number of years of regular daily smoking, and other smoking characteristics (Brown et al., 2002) . To describe the sample, smoking rate was obtained from the question, "Since you started regular daily smoking, what is the average number of cigarettes you smoked per day?" The number of years of regular daily smoking was derived from the question, "How many years altogether have you been a regular daily smoker?".
Structured Clinical Interview-Nonpatient Version for DSM-IV (SCID-I/NP). Diagnostic assessments of past
year Axis I psychopathology were conducted using the SCID-I/NP (First et al., 1994) . All SCID-I/NP interviews were administered by trained research assistants or doctoral-level staff and supervised by independent doctoral-level professionals. Interviews were audio taped, and the reliability of a random selection of 12.5% of interviews was checked (M.J.Z.) for accuracy; no cases of (diagnostic coding) disagreement were noted.
Positive and Negative Affect Scale. The Positive and
Negative Affect Scale (PANAS) (Watson et al., 1988 ) is a selfreport measure that requires participants to rate the extent to which they experience 20 different feelings and emotions (eg, nervous and interested) based on a Likert scale ranging from 1 ("very slightly or not at all") to 5 ("extremely"). The measure yields two factors, negative affect and positive affect, and has strong documented psychometric properties (Watson et al., 1988) . The PANAS negative affectivity subscale (PANAS-NA; 10 items) was utilized in this study. The PANAS-NA internal consistency was excellent (Cronbach α = 0.92).
Procedure
A community sample of adult daily smokers was recruited to participate in a randomized controlled dual-site clinical trial, examining the efficacy of two smoking cessation interventions. Individuals responding to study advertisements were scheduled for an in-person, baseline assessment to evaluate study inclusion and exclusion criteria. After providing written informed consent, participants completed an interview and a computerized battery of self-report questionnaires. The institutional review board at each study site approved the study protocol, and all study procedures were conducted in compliance with ethical standards of the American Psychological Association. The current cross-sectional study is based on secondary analyses of baseline (pretreatment) data for a subset of the sample.
Analytic Strategy
First, outliers and descriptive data were examined. Second, analyses were conducted using bootstrapping techniques through PROCESS, a conditional modeling program that utilizes an ordinary least squares-based path analytical framework to test for both direct and indirect effects (Hayes, 2013) . Bootstrapping is the recommended approach when data distribution is nonnormal or unknown (Kelley, 2005; Kirby and Gerlanc, 2013) ; thus, nonnormality was not a principal concern. Models included PDS-IAH as the predictor and dysphoria as the explanatory variable. On the basis of previous research Gonzalez et al., 2008) , relevant vari-ables that also correlated with study variables were entered as covariates and included sex, PANAS-NA, and time since trauma. Four independent models were run with AIS (model 1), BCS (model 2), RFS-NA (model 3), and SCQ-NR (model 4) as criterion variables (see Fig. 1 ). All models were subjected to 10,000 bootstrap resamplings, and a 95-percentile confidence interval (CI) was estimated Hayes, 2004, 2008; Hayes, 2009 ). Finally, we performed analyses reversing PDS-IAH and dysphoria to further strengthen results (Preacher and Hayes, 2004) . Given the cross-sectional nature of the study, we included these analyses to disprove alternative hypotheses and to further lend support to the explanatory priority of PDS-IAH and dysphoria. Finally, to further strengthen interpretation of results, all models and reverse models were run using PDS-total.
RESULTS
Descriptive Analyses
No outliers were observed, and 4 cases were removed due to missing data; thus, 189 cases comprised the sample included in the analyses. The removal of these cases did not influence the overall pattern or statistical significance of the results. Means, standard deviations, and bivariate correlations are presented in Table 1 .
Main Analyses
Regression results for paths a, b, c, and c' are presented in Table 2 . Model 1 with AIS as the criterion revealed a significant total effect model (R 2 = 0.104; F 4, 184 = 5.356; P < 0.001) with PDS-IAH as the predictor and all covariates entered. The model was significant after adding dysphoria and accounted for greater variance (R 2 = 0.163; F 5, 183 = 7.145; P < 0.001). The direct effect of PDS-IAH on AIS after entering dysphoria was not significant. Regarding the test of the indirect effect, higher rating of PDS-IAH predicted greater AIS indirectly through dysphoria (effect a*b).
Model 2 with BCS as the criterion revealed a significant total effect model (R 2 = 0.168; F 4, 184 = 9.305; P < 0.001) with PDS-IAH as the predictor and all covariates entered. The model was significant after adding dysphoria and accounted for greater variance (R 2 = 0.241, F 5, 183 = 11.641; P < 0.001). The direct effect of PDS-IAH on BCS after entering dysphoria was not significant. Regarding the test of the indirect effect, higher rating of PDS-IAH predicted greater BCS indirectly through dysphoria (effect a*b).
Model 3 with RFS-NA as the criterion revealed a significant total effect model (R 2 = 0.260; F 4, 184 = 16.122; P < 0.001) with PDS-IAH as the predictor and all covariates entered. The model was significant after adding dysphoria and accounted for greater variance (R 2 = 0.314; F 5, 183 = 16.737; P < 0.001). The direct effect of PDS-IAH on RFS-NA after entering dysphoria was not significant. Regarding the test of the indirect effect, higher rating of PDS-IAH predicted greater RFS-NA indirectly through dysphoria (effect a*b).
Model 4 with SCQ-NR as the criterion revealed a significant total effect model (R 2 = 0.184; F 4, 184 = 10.399; P < 0.001) with PDS-IAH as the predictor and all covariates entered. The model was significant after adding dysphoria and accounted for greater variance (R 2 = 0.213; F 5, 183 = 9.893; 
Specificity Analyses
To further strengthen interpretation of results, the proposed predictor (PDS-IAH) and potential explanatory (dysphoria) variables were reversed for each of the 4 models tested previously. Tests of the indirect effects in these models were estimated on the basis of 10,000 bootstrap resamples, and all results of the reversed models were not significant.
Finally, PDS-total indirectly related to AIS (b = 0.108; 95% CI, 0.034-0.219), BCS (b = 0.122; 95% CI, 0.042-0.249), RFS-NA (b = 0.008; 95% CI, 0.003-0.015), and SCQ-NR (b = 0.012; 95% CI, 0.004-0.027) through dysphoria. Thus, the overall main findings did not differ when models were explored with PDS-total. All reverse models were not significant.
DISCUSSION
Posttraumatic stress symptom severity (ie, intrusion, avoidance, or hyperarousal symptom clusters) was significantly related to the tendency to respond with inflexibility/ avoidance in the presence of aversive smoking-related thoughts, feelings, or internal sensations; perceived barriers to smoking cessation; negative affect reduction motivation for smoking; and negative affect reduction/negative reinforcement expectancies from smoking through dysphoria. The observed effects were evident above and beyond the variance accounted for by sex, negative affectivity, and time since trauma. Results indicated that dysphoria at least partially explained the relationship between posttraumatic stress symptom severity and the criterion variables. Although the present research design does not permit explication of the temporal ordering of the observed associations, we attempted to improve confidence in the observations by evaluating an alternative model in which the predictors (PDS-IAH and dysphoria) were reversed. All models emerged as not significant, indicating that the studied smoking variables are not solely a set of "interrelated constructs." Rather, these variables may operate as part of a directional pathway leading from posttraumatic stress symptom severity to dysphoria to smoking processes. In addition, we explored whether the inclusion of dysphoria items on the posttraumatic stress symptom severity measure would influence results. The inclusion of these items did not yield different results than when the items were excluded.
Clinically, the present findings suggest that it may be advisable to address dysphoria among trauma-exposed smokers seeking smoking cessation treatment. Although additionally research is needed, it may be that smoking cessation programs for trauma-exposed individuals that incorporate depression management education and therapeutic training are more efficacious over standard smoking cessation programs. Although addressing PTSD may yield positive results for trauma-exposed smokers who seek clinical services, some trauma-exposed smokers may benefit by targeting dysphoric symptoms to facilitate changes in smoking processes. Thus, depression-oriented interventions may be a useful compliment or supplementary intervention tactic for trauma-exposed smokers, particularly those who may be less apt to "engage" with therapeutic tactics oriented fully on PTSD symptoms.
There are a number of study limitations. First, the temporal relationship between posttraumatic stress and dysphoria is unclear. The cross-sectional nature of the study design did not allow for testing of temporal sequencing. On the basis of the present results, future prospective studies are necessary to determine directional effects of these relationships. Second, our sample consisted of primarily white, community-recruited, treatment-seeking, trauma-exposed daily cigarette smokers with a moderate smoking rate. This limitation restricts the generalizability of findings. Future studies may benefit by sampling ethnically diverse, lighter and heavier smokers to ensure the generalizability of the results to the general smoking population. Third, this study relied on self-report measures. Future research could benefit by utilizing multi-method approaches and minimizing the role of method variance in the observed relationships. Fourth, creating a summary score for PDS without including the dysphoria subscale may make it difficult to know exactly what was measured and how it applies to understanding the clinical presentation of PTSD. Although additional analyses explored the models utilizing the entire construct, future researchers should consider exploring explanatory pathways between each PTSD symptom clusters and cognitive-based processes of smoking. Finally, we did not have sufficient data to complete analyses on smokers with PTSD; thus, the degree to which study findings are specifically applicable to treatment-seeking individuals with PTSD is uncertain. To further gauge the clinical significance of the current findings for smokers with PTSD, it would be important for future work to replicate this model with smokers who have PTSD.
CONCLUSIONS
Overall, this study serves as an initial investigation into the nature of the association among posttraumatic stress, dysphoria, and a relatively wide range of clinically significant smoking processes with adult treatment-seeking, trauma-exposed smokers. The findings of this study are a first step in informing possible underlying variables that may link intrusion, avoidance, and hyperarousal symptoms and cognitive process of smoking. Future work is needed to better understand the extent to which trauma-exposed smokers with symptoms of posttraumatic stress may benefit from addressing dysphoria during a smoking cessation program.
